Get the Stockscreener App
3.50
0.00%
0.00
After Hours:
3.99
0.49
+14.00%
Neonc Technologies Holdings Inc stock is traded at $3.50, with a volume of 196.30K.
It is up +0.00% in the last 24 hours and down -22.05% over the past month.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
See More
Previous Close:
$3.50
Open:
$3.47
24h Volume:
196.30K
Relative Volume:
2.07
Market Cap:
$90.76M
Revenue:
$40,000
Net Income/Loss:
$-38.64M
P/E Ratio:
-1.9007
EPS:
-1.8414
Net Cash Flow:
$-22.21M
1W Performance:
+1.16%
1M Performance:
-22.05%
6M Performance:
-67.35%
1Y Performance:
-26.93%
1-Day Range:
$3.31
$3.61
1-Week Range:
$3.31
$3.62
52-Week Range:
$3.005
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Name
Neonc Technologies Holdings Inc
Sector
Industry
Phone
310 663 7831
Address
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
3.50 | 89.21M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
523.91 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
808.05 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
866.11 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.97 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
359.00 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neonc Technologies Holdings Inc Stock (NTHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-26 | Initiated | Alliance Global Partners | Buy |
| May-18-26 | Initiated | Maxim Group | Buy |
| Apr-24-26 | Initiated | BTIG Research | Buy |
Neonc Technologies Holdings Inc Stock (NTHI) Latest News
NTHI|NeOnc Technologies Holdings Inc|Price:3.430| - TradingKey
Neonc Technologies Holdings, Inc. Announces Appointment of Nasim Shomali to Board of Directors, Effective July 1, 2026 - marketscreener.com
NeOnc Technologies Holdings, Inc. Revenue Breakdown – NASDAQ:NTHI - TradingView
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors - Asianet Newsable
NeOnc appoints Nasim Shomali to board of directors - Investing.com
NeOnc Technologies Holdings Appoints Nasim Shomali to Board of Directors - Quiver Quantitative
NeOnc appoints Nasim Shomali to board of directors By Investing.com - Investing.com Canada
Press Release: NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to Its Board of Directors - Moomoo
NeOnc Technologies Holdings Inc (NTHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NeOnc Technologies Holdings Inc - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NTHI|NeOnc Technologies Holdings Inc|Price:3.430|Chg%:-0.200 - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Institutional Confidence - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Cash Flow - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Balance Sheet - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Income Statement - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeOnc Technologies (NTHI) Shows Resilience with 1.68% Gain, Testing Key ResistanceDefined Outcome ETF - dars.gov.et
NeOnc Shares Rise on Abu Dhabi Approval for Brain-Cancer Drug Trial - Moomoo
Enterprise value to EBITDA forward of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Enterprise value to EBIT forward of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Enterprise value to revenue forward of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Price to earnings forward of NeOnc Technologies Holdings, Inc. – BOATS:NTHI - TradingView
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition - Sahm
Neonc TechnologiesCancels July 9 FDA Meeti - Moomoo
NEONC TECHNOLOGIESTO UPDATE NEO212 DEVELOPMENT PLAN AFTER INCORPORATING FDA FEEDBACK - Moomoo
NeOnc receives FDA feedback on NEO212 manufacturing requirements By Investing.com - Investing.com Nigeria
NeOnc receives FDA feedback on NEO212 manufacturing requirements - Investing.com India
NeOnc receives FDA CMC feedback on NEO212; capsule-to-tablet bioavailability study advised - TradingView
NeOnc Technologies (NASDAQ: NTHI) receives detailed FDA CMC feedback on NEO212 - Stock Titan
Bullish NeOnc Technologies Holdings Insider Buying Worth US$615.6k Yet To Pay Off - simplywall.st
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
Form 4 Neonc Technologies Holdings Inc For: 13 July By Investing.com - Investing.com Nigeria
NEONC Technologies (NTHI) awards director 50,000 restricted shares - Stock Titan
Neonc Technologies (NTHI) director discloses holding 160 common shares - Stock Titan
NeOnc Technologies Holdings, Inc. (NTHI) 8-K Filing: Director and Officer Changes Announced – Nasdaq Emerging Growth Company Update – Minichart - Minichart
NeOnc Technologies Adds New Director Amid Governance Focus - TipRanks
New NeOnc (NASDAQ: NTHI) director is CEO's niece - Stock Titan
NeOnc Technologies Holdings, Inc. Financial Disclosures & SEC Filings - TradingView
NeOnc Technologies Holdings (NTHI) Investor Relations, Earnings Summary & Outlook - Quartr
NTHI Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Investment PhaseNext Quarter Guidance - dars.gov.et
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
NTHI Q1 2026 Earnings: EPS Misses Estimates as Company Focuses on Pipeline DevelopmentEarnings Expansion Phase - dars.gov.et
NTHI Forecast — Price Target — Prediction for 2027 - TradingView
NeOnc Technologies Holdings, Inc. Actuals & Estimates (NASDAQ:NTHI) - TradingView
Neonc Technologies Holdings Inc Stock (NTHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neonc Technologies Holdings Inc Stock (NTHI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Apr 28 '26 |
Buy |
4.52 |
10,000 |
45,180 |
3,062,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Apr 23 '26 |
Buy |
4.88 |
500 |
2,440 |
134,760 |
| Heshmatpour Amir F | President |
Apr 23 '26 |
Buy |
4.90 |
10,000 |
49,000 |
3,052,000 |
| SUH, DAVID JR. | Chief Accounting Officer |
Apr 09 '26 |
Buy |
5.00 |
200 |
1,000 |
111,866 |
| Heshmatpour Amir F | President |
Apr 10 '26 |
Buy |
4.89 |
10,000 |
48,950 |
3,042,000 |
| Heshmatpour Amir F | President |
Apr 08 '26 |
Buy |
5.61 |
10,000 |
56,050 |
3,027,000 |
| Heshmatpour Amir F | President |
Apr 09 '26 |
Buy |
5.19 |
5,000 |
25,950 |
3,032,000 |
| Heshmatpour Amir F | President |
Apr 02 '26 |
Buy |
6.09 |
20,000 |
121,798 |
3,012,000 |
| Heshmatpour Amir F | President |
Apr 06 '26 |
Buy |
6.32 |
5,000 |
31,600 |
3,017,000 |
| Heshmatpour Amir F | President |
Nov 21 '25 |
Buy |
6.07 |
24,000 |
145,600 |
2,986,000 |
0.82%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):